An implantable bioartificial kidney being developed by The Kidney Project – a nationwide collaboration led by Bangladeshi American Professor Shuvo Roy of U.C. San Francisco and Dr. William Fissell of ...
Compared with placebo, semaglutide lowered risks for adverse kidney outcomes and mortality across the chronic kidney disease spectrum, according to study data published in Clinical Journal of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results